NDAQ

Nasdaq, Inc.

$92.19

+2.06%
Oct 5, 2026
Bobby Quantitative Model
Nasdaq, Inc. operates a diversified financial infrastructure and technology platform spanning three core segments: Capital Access Platforms (listing, index, and data businesses), Market Services (equities, options, and fixed-income trading venues), and Financial Technology (capital markets software, regulatory compliance, and anti-financial-crime solutions built largely through the Verafin and Adenza acquisitions). While globally recognized for its flagship U.S. equity exchange, the company has deliberately repositioned itself as a technology-forward, recurring-revenue enterprise, with roughly three-quarters of sales now derived from non-trading, subscription-like businesses. The current investor narrative centers on this ongoing transformation — management is pitching Nasdaq as a mission-critical software and data provider to the financial system rather than a volume-sensitive exchange operator, and recent quarterly results showing 21% year-over-year revenue growth have reinforced that story. At the same time, the stock is drawing attention for its role in reshaping public markets: Nasdaq's new 'fast entry' index inclusion rules and its SEC-approved tokenized settlement pilot have made it a focal point in debates over how mega-IPOs like SpaceX and next-generation fintech listings will be absorbed by passive funds. The debate among investors is whether Nasdaq's premium valuation is justified by durable, high-margin software economics or whether it has gotten ahead of itself given the stock's recent underperformance relative to the broader market.

People also watch

S&P Global

S&P Global

SPGI

Analysis
CME Group

CME Group

CME

Analysis
Intercontinental Exchange

Intercontinental Exchange

ICE

Analysis
Moody's Corporation

Moody's Corporation

MCO

Analysis
Coinbase

Coinbase

COIN

Analysis

BobbyInvestment Opinion: Should I buy NDAQ Today?

The synthesized recommendation is Buy, with a one-sentence thesis that Nasdaq's accelerating revenue growth, expanding margins, and reasonable forward valuation (19.31x forward PE) make the recent underperformance a buying opportunity. The analyst consensus rating of 'buy' (mean 1.83) and average target price of $108.94 imply 20.6% upside, anchoring the bullish view. The company's transformation into a technology-forward, recurring-revenue enterprise is gaining traction, as evidenced by the 21.15% YoY revenue growth in Q2 2026.

The supporting evidence is compelling: revenue grew 21.15% YoY in Q2 2026, gross margin expanded to 59.2% from 44.4% in Q3 2025, trailing free cash flow is $1.951 billion, and the forward PE of 19.31x is well below the trailing PE of 31.03x. The PEG ratio of 0.51 suggests the stock is undervalued relative to its growth rate. Additionally, the dividend yield of 1.08% with a payout ratio of 33.6% provides income and room for continued buybacks. Compared to the broader financial data and exchange industry, Nasdaq's net margin of 21.8% and operating margin of 28.4% are above average, justifying a premium multiple.

The biggest risks that could invalidate the thesis are a deceleration in revenue growth, integration challenges from Adenza and Verafin, and multiple compression due to sector rotation. The rating would upgrade to a strong buy if revenue growth sustains above 15% for multiple quarters and the forward PE remains below 20x. It would downgrade to Hold if revenue growth falls below 10% or if the forward PE exceeds 25x without commensurate growth. The stock appears undervalued relative to its history and growth prospects, trading at a forward PE of 19.31x versus a historical range of 20x to over 40x.

Sign up to view all

NDAQ 12-Month Price Forecast

The forward-looking view is bullish, supported by the recent revenue acceleration, margin expansion, and reasonable forward valuation. The company's transformation into a technology-forward, recurring-revenue enterprise is gaining traction, and the analyst community remains constructive with a consensus buy rating and no sell ratings. The main risk is that the Q2 revenue acceleration proves temporary; if growth decelerates, the premium multiple could compress. I would upgrade to high confidence if Q3 2026 results show sustained revenue growth above 15% and margin expansion continues. I would downgrade to neutral if revenue growth falls below 10% or if the forward PE exceeds 25x without commensurate growth.

Historical Price
Current Price $92.19
Average Target $110.00
High Target $132.00
Low Target $76.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Nasdaq, Inc.'s 12-month outlook, with a consensus price target around $109.19 and implied upside of +18.4% versus the current price.

Average Target

$109.19

0 analysts

Implied Upside

+18.4%

vs. current price

Analyst Count

—

covering this stock

Price Range

$84 - $132

Analyst target range

Wall Street coverage of Nasdaq is robust, with 16 analysts contributing to the consensus. The recommendation distribution leans bullish, with a consensus recommendation of 'buy' and a recommendation mean of 1.83 (on a scale where 1.0 is a strong buy and 5.0 is a sell). The average price target is $108.94, which implies approximately 20.6% upside from the current price of $90.33. This is a meaningful gap between where the stock trades and where analysts believe it should be, suggesting the recent underperformance is viewed as a buying opportunity rather than a reflection of deteriorating fundamentals. The consensus EPS estimate of $6.15 for the forward year, combined with the average revenue estimate of $7.563 billion, implies analysts expect continued top-line growth and margin expansion.

The target range is wide, spanning from a low of $84.00 to a high of $132.00 — a spread of $48, or roughly 57% of the low target. This wide dispersion signals significant uncertainty about the company's trajectory. The high target of $132 would require substantial multiple expansion and likely assumes that the Adenza and Verafin acquisitions drive faster-than-expected revenue synergies, that the tokenized settlement pilot and fast-entry IPO rules become meaningful revenue drivers, and that the company successfully re-rates toward a software-like multiple. The low target of $84 — about 7% below the current price — prices in a scenario where revenue growth decelerates, integration costs run higher than expected, or the premium multiple compresses as investors rotate toward cheaper financials. Institutional ratings show a stable-to-positive bias: recent actions from Barclays (Overweight), TD Cowen (Buy), Morgan Stanley (Overweight), and Raymond James (Outperform) are all constructive, with no downgrades in the recent data. Keefe, Bruyette & Woods maintains a more cautious Market Perform rating, reflecting the debate around valuation. The absence of any sell ratings and the clustering of targets well above the current price suggest that the analyst community views the recent pullback as a temporary dislocation rather than a fundamental deterioration.

Drowning in data?

Find the real signal!

Bulls vs Bears: NDAQ Investment Factors

The bull case currently has stronger evidence, driven by the dramatic revenue reacceleration to 21.15% YoY, gross margin expansion to 59.2%, and a forward PE of 19.31x that is reasonable for a company with these growth and margin characteristics. The bear case rests primarily on the stock's persistent relative underperformance and premium absolute valuation multiples, but these are largely explained by the company's ongoing transformation toward a software-like business model. The single most important tension is whether the Q2 2026 revenue acceleration is sustainable or a one-time event; if growth decelerates back toward the low single digits seen in prior quarters, the premium multiple would be vulnerable to significant compression. Conversely, if the company can string together multiple quarters of double-digit growth, the stock is likely to re-rate toward analyst targets. The risk/reward appears skewed to the upside given the 20.6% implied upside to the average analyst target and the absence of sell ratings.

Bullish

  • Revenue Growth Accelerated to 21.15% YoY: Q2 2026 revenue of $2.532 billion grew 21.15% year-over-year, a sharp acceleration from roughly 2.2% growth in Q1 2026 and flat growth in Q4 2025. This reacceleration suggests the Adenza and Verafin acquisitions are now contributing meaningfully and that integration drag has subsided.
  • Forward PE of 19.31x with PEG of 0.51: The forward PE of 19.31x is well below the trailing PE of 31.03x, implying the market expects substantial earnings growth. The PEG ratio of 0.51 is well below 1.0, indicating the stock is inexpensive on a growth-adjusted basis if forward EPS of $6.15 is achieved.
  • Analyst Consensus Buy with 20.6% Upside: 16 analysts have a consensus 'buy' rating (mean 1.83) and an average price target of $108.94, implying 20.6% upside from the current price of $90.33. No sell ratings and recent constructive actions from Barclays, TD Cowen, Morgan Stanley, and Raymond James reinforce the bullish view.
  • Gross Margin Expanded to 59.2%: Gross margin expanded dramatically from 44.4% in Q3 2025 to 59.2% in Q2 2026, reflecting a favorable revenue mix shift toward higher-margin software and data products. This margin expansion supports the thesis that Nasdaq is successfully transforming into a technology-forward, recurring-revenue enterprise.

Bearish

  • Persistent Underperformance vs. S&P 500: NDAQ has gained only 3.42% over the trailing twelve months versus the S&P 500's 15.01% advance, a relative strength of -11.59 percentage points. Year-to-date, the stock is down 6.55% while the S&P 500 is up 12.86%, a -19.41 point relative strength gap.
  • Premium Valuation vs. Exchange Peers: The price-to-sales ratio of 6.75x and price-to-book ratio of 4.53x are elevated versus traditional exchange peers. The EV/EBITDA of 20.64x and EV/Sales of 10.69x are rich on an absolute basis, leaving the stock vulnerable to multiple compression if growth decelerates.
  • Tight Current Ratio of 1.005: The current ratio of 1.005 indicates virtually no short-term liquidity cushion, a risk if customer-related assets or liabilities shift unexpectedly. Additionally, the debt-to-equity ratio of 0.81 and $86 million quarterly interest expense reflect the leverage taken on for the Adenza acquisition.
  • Recent Momentum Deterioration: The stock is down 5.63% over the past month versus a 0.59% gain for SPY, producing a relative strength reading of -6.22 percentage points. This sharp near-term underperformance suggests waning investor enthusiasm despite the strong Q2 results.

NDAQ Technical Analysis

Nasdaq's stock is in a choppy, range-bound consolidation phase rather than a clean directional trend. Over the trailing twelve months the shares have gained just 3.42%, dramatically lagging the S&P 500's 15.01% advance, and the stock is down 6.55% year-to-date. At a current price of $90.33, the stock sits at roughly 54.6% of its 52-week range (52-week low of $76.55, 52-week high of $101.79), placing it squarely in the middle of its annual band — neither a momentum leader nor a deeply discounted falling knife, but a market-performer that has lost relative ground. The 52-week range itself spans about $25.24, or roughly 33% of the low, indicating meaningful but not extreme volatility for a large-cap financial infrastructure name.

Short-term momentum has deteriorated sharply and now diverges from the longer-term picture. The stock is down 5.63% over the past month versus a 0.59% gain for SPY, producing a relative strength reading of -6.22 percentage points — a clear signal of near-term underperformance. Over three months, however, NDAQ is up 6.70% against SPY's 3.34%, giving it a positive 3.36-point relative strength spread, which suggests the recent weakness is a pullback within a modestly improving intermediate trend rather than the start of a sustained breakdown. The six-month picture is again negative, with NDAQ up 4.25% versus SPY's 17.35% (relative strength of -13.10), underscoring that the stock has been a persistent laggard even as it has recovered from its June lows near $76.85. This pattern — strong 3-month, weak 1-month and 6-month — is characteristic of a stock that rallied hard off a bottom and is now digesting those gains.

Key technical levels are well defined. Immediate support sits at the 52-week low of $76.55, with the June trough around $76.85 reinforcing that zone; a breakdown below $76.55 would signal a resumption of the downtrend and likely target new lows. Resistance is anchored at the 52-week high of $101.79, and the stock has repeatedly failed in the $98–$100 area (peaking at $99.47 in late August), making that the near-term ceiling to watch. A decisive breakout above $101.79 would confirm a new uptrend and likely draw momentum buyers, while continued rejection there keeps the stock range-bound. With a beta of 0.974, NDAQ is slightly less volatile than the broad market — a defensive characteristic that supports smaller position-sizing adjustments but also means the stock is unlikely to deliver outsized upside without a fundamental catalyst. The maximum drawdown of -23.9% over the period is a reminder that even low-beta financial infrastructure names can experience meaningful peak-to-trough declines.

Beta

1.00

1.00x market volatility

Max Drawdown

-23.9%

Largest decline past year

52-Week Range

$77-$102

Price range past year

Annual Return

+5.2%

Cumulative gain past year

PeriodNDAQ ReturnS&P 500
1m-4.8%+0.6%
3m+6.7%+3.6%
6m+4.7%+14.6%
1y+5.2%+15.8%
ytd-4.6%+13.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

NDAQ Fundamental Analysis

Nasdaq's revenue trajectory is clearly accelerating. The most recent quarter (Q2 2026, ended June 30) delivered revenue of $2.532 billion, up 21.15% year-over-year from $2.09 billion in Q2 2025. This marks a sharp acceleration from the prior-year comparisons: Q1 2026 revenue of $2.137 billion grew roughly 2.2% over Q1 2025's $2.09 billion, and Q4 2025's $2.08 billion was essentially flat versus Q4 2024's $2.03 billion. The Q2 2026 jump appears driven by broad-based strength across segments, with Market Services contributing $1.372 billion, Capital Access Platforms $621 million, and Market Technology $539 million. The reacceleration is a critical data point for the bull case — it suggests the Adenza and Verafin acquisitions are now contributing meaningfully and that the company is past the integration drag that muted growth in prior periods.

Profitability is robust and improving. Q2 2026 net income was $507 million on a 20.0% net margin, with gross profit of $1.499 billion (59.2% gross margin) and operating income of $877 million (34.6% operating margin). The company's trailing net margin of 21.8% and operating margin of 28.4% compare favorably to the broader financial data and exchange industry, where net margins typically range from the mid-teens to low-20s. The trend is favorable: net income has risen from $423 million in Q3 2025 to $519 million in Q1 2026 and $507 million in Q2 2026, while gross margin expanded from 44.4% in Q3 2025 to 59.2% in Q2 2026 — a dramatic improvement that likely reflects a favorable revenue mix shift toward higher-margin software and data products. The Q1 2026 gross margin of 65.8% was even higher, though some quarter-to-quarter volatility is expected given the mix of trading and subscription revenue.

Balance sheet and cash flow metrics are solid but not without leverage. The debt-to-equity ratio stands at 0.81, and the current ratio is a tight 1.005, indicating limited short-term liquidity cushion — a common characteristic of exchange operators that hold significant customer-related assets and liabilities. Free cash flow on a trailing-twelve-month basis is $1.951 billion, and Q2 2026 free cash flow was $634 million on operating cash flow of $711 million, with capital expenditures of just $77 million — a remarkably capital-light model. Return on equity is a healthy 14.6%, and return on assets is 5.85%. The company returned significant capital to shareholders in Q2 2026, paying $174 million in dividends and repurchasing $355 million of stock, while also repaying $162 million of debt. The dividend yield of 1.08% with a payout ratio of 33.6% leaves ample room for continued buybacks and dividend growth. The primary risk is the $86 million quarterly interest expense and the elevated total debt load from the Adenza acquisition, but with interest coverage of roughly 10.2x, the company generates more than enough operating income to service its obligations.

Quarterly Revenue

$2.5B

2026-06

Revenue YoY Growth

+21.1%

YoY Comparison

Gross Margin

59.2%

Latest Quarter

Free Cash Flow

$2.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Capital Access Platforms
Market Technology
Market Services

Open an Account, get $2 TSLA now!

Valuation Analysis: Is NDAQ Overvalued?

Because Nasdaq is solidly profitable — Q2 2026 net income of $507 million and trailing EPS of $0.032 (reflecting a one-time item) with forward EPS estimates of $6.15 — the price-to-earnings ratio is the appropriate primary valuation metric. The trailing PE of 31.03x drops to a forward PE of 19.31x, a roughly 38% compression that implies the market expects substantial earnings growth over the next twelve months. That gap is wide and suggests investors are pricing in the full realization of Adenza and Verafin synergies, continued revenue acceleration, and margin expansion. The PEG ratio of 0.51 — well below 1.0 — indicates that, on a growth-adjusted basis, the stock is not expensive if those earnings estimates are met.

Relative to the financial data and stock exchange industry, Nasdaq trades at a premium on most metrics. Its price-to-sales ratio of 6.75x and price-to-book ratio of 4.53x are elevated versus traditional exchange peers, though the comparison is complicated by Nasdaq's growing software and data revenue mix, which commands higher multiples than pure trading businesses. The EV/EBITDA of 20.64x and EV/Sales of 10.69x are rich on an absolute basis but reflect the market's willingness to pay up for recurring, high-margin revenue. The forward PE of 19.31x is arguably reasonable for a company growing revenue at 21% with 59% gross margins, and the PEG of 0.51 suggests the premium is justified by the growth trajectory. The key risk is that if revenue growth decelerates back toward the low single digits seen in prior quarters, the premium multiple would be vulnerable to compression.

Historically, Nasdaq's valuation sits in the middle-to-lower portion of its own range. The trailing PE of 31.03x compares to a historical range that has spanned from roughly 20x to over 40x in recent years — the stock traded at 38.1x in Q2 2024 and 40.4x in Q4 2023, so the current 31x is well below those peaks. The PS ratio of 6.75x is dramatically lower than the 17.6x–26.7x range seen in 2025–2026 historical data, though that discrepancy likely reflects differences in how the ratio is calculated across data sources. The price-to-book of 4.53x is near the middle of its multi-year band (which has ranged from roughly 2.9x to 5.5x). Overall, the valuation does not appear stretched relative to Nasdaq's own history, and the forward PE below 20x suggests the market is not pricing in heroic assumptions — provided the earnings growth materializes.

PE

31.0x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 20x~40x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

20.6x

Enterprise Value Multiple

Investment Risk Disclosure

Nasdaq's financial and operational risks are moderate but manageable. The debt-to-equity ratio of 0.81 and $86 million quarterly interest expense reflect the leverage taken on for the Adenza acquisition, though interest coverage of roughly 10.2x provides a comfortable cushion. The current ratio of 1.005 is tight, indicating limited short-term liquidity, which is common for exchange operators but still a vulnerability if customer-related assets or liabilities shift unexpectedly. Revenue concentration remains a consideration: while the company has diversified into software and data, the Capital Access Platforms segment (42.5% of sales) and Market Services (22.5%) are still tied to market activity and listing volumes, which can be cyclical. The trailing PE of 31.03x and price-to-sales of 6.75x mean the stock is priced for continued growth; any earnings miss or revenue deceleration could trigger a sharp re-rating.

Market and competitive risks are significant given the premium valuation. The stock trades at a premium to traditional exchange peers on most metrics, and the forward PE of 19.31x assumes substantial earnings growth. If revenue growth decelerates back toward the low single digits seen in prior quarters, the multiple could compress toward the historical low end of 20x, implying a price near $123 based on forward EPS of $6.15—though that still represents upside from current levels. Competitive threats include other exchanges and data providers investing in similar technology, as well as the risk that the tokenized settlement pilot and fast-entry IPO rules fail to generate meaningful revenue. Macro sensitivity is moderate with a beta of 0.974, but the stock has underperformed the S&P 500 by 11.59 percentage points over the past year, suggesting sector rotation away from financials could continue. Recent news highlights the SpaceX IPO and Nasdaq's fast-entry rules, which could pressure other tech stocks through passive fund rebalancing, indirectly affecting Nasdaq's listing and index businesses.

The worst-case scenario would involve a combination of revenue growth decelerating to low single digits, integration costs from Adenza and Verafin running higher than expected, and a broad market rotation away from premium-valued financials. In this scenario, the stock could retest its 52-week low of $76.55, representing a decline of approximately 15.3% from the current price of $90.33. The analyst low target of $84 implies a more modest 7% downside, but the 52-week low and the maximum drawdown of -23.9% over the period suggest that a more severe selloff is possible if fundamentals deteriorate. A break below the June trough of $76.85 would likely accelerate selling and target new lows, potentially down to the $70–$75 range. Investors should be prepared for a drawdown of 15–25% in an adverse scenario, which is consistent with the stock's historical volatility.

FAQ

The key risks include: 1) Financial risk: the current ratio of 1.005 indicates limited short-term liquidity, and the debt-to-equity ratio of 0.81 with $86 million quarterly interest expense reflects leverage from the Adenza acquisition. 2) Valuation risk: the price-to-sales ratio of 6.75x and EV/EBITDA of 20.64x are premium multiples that could compress if revenue growth decelerates. 3) Competitive risk: other exchanges and data providers are investing in similar technology, and the tokenized settlement pilot may not generate meaningful revenue. 4) Macro risk: with a beta of 0.974, the stock is sensitive to market downturns, and it has already underperformed the S&P 500 by 11.59 percentage points over the past year. The most severe risk is a combination of revenue deceleration and multiple compression, which could drive the stock to the 52-week low of $76.55.

The 12-month forecast includes three scenarios: a bull case (30% probability) with a target range of $120-$132, driven by sustained 20%+ revenue growth and successful new initiatives; a base case (50% probability) with a target range of $105-$115, assuming mid-teens revenue growth and stable margins; and a bear case (20% probability) with a target range of $76-$84, reflecting revenue deceleration and multiple compression. The base case is most likely, with the key assumption that revenue growth averages 12-15% over the next four quarters and gross margins remain above 55%. The analyst average target of $108.94 aligns with the base case, implying 20.6% upside from the current price.

NDAQ appears undervalued relative to its growth prospects and historical valuation. The forward PE of 19.31x is well below the trailing PE of 31.03x and the historical range of 20x to over 40x, while the PEG ratio of 0.51 is well below 1.0. The price-to-sales ratio of 6.75x and price-to-book of 4.53x are elevated versus traditional exchange peers, but this premium is justified by the company's growing software and data revenue mix, which commands higher multiples. The market is pricing in substantial earnings growth, as evidenced by the 38% compression from trailing to forward PE, but the current valuation does not appear to require heroic assumptions. If forward EPS of $6.15 is achieved, the stock is trading at a discount to its growth rate.

From a risk/reward perspective, NDAQ appears to be a good buy for investors with a medium-to-long-term horizon. The stock trades at $90.33, implying 20.6% upside to the average analyst target of $108.94, and the forward PE of 19.31x is reasonable for a company growing revenue at 21.15% with a 59.2% gross margin. The biggest downside risk is a retest of the 52-week low of $76.55, which would represent a 15.3% decline. However, the consensus buy rating (mean 1.83) and absence of sell ratings suggest the analyst community views the recent pullback as a buying opportunity. For investors comfortable with moderate volatility (beta 0.974) and a 12-18 month holding period, NDAQ offers an attractive risk/reward profile.

NDAQ is more suitable for long-term investment than short-term trading. The company is in a growth stage, transforming into a technology-forward enterprise, with a beta of 0.974 indicating slightly lower volatility than the market. The dividend yield of 1.08% with a payout ratio of 33.6% provides modest income, and the capital-light model generates strong free cash flow of $1.951 billion TTM. Earnings visibility is improving, but the wide analyst target range ($84-$132) suggests uncertainty in the near term. Short-term traders may find opportunities around technical levels ($76.55 support, $101.79 resistance), but the stock's recent choppy consolidation and relative underperformance make timing difficult. A suggested minimum holding period is 12-18 months to allow the transformation story to fully play out and for the stock to re-rate toward analyst targets.